Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Koch-Nolte

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Immunological Reviews|August 30, 2024
Nanobody-based heavy chain antibodies and chimeric antibodiesFriedrich Koch-Nolte
The FEBS Journal|June 19, 2013
Physiology of ADP-ribosylationFriedrich Koch-Nolte, Mathias Ziegler
Frontiers in Immunology|November 22, 2018
Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple MyelomaPeter Bannas, Friedrich Koch-Nolte
Frontiers in Immunology|December 8, 2017
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor TherapeuticsPeter Bannas, Julia Hambach, Friedrich Koch-Nolte
Nucleic Acids Research|September 23, 2006
ZBP1 subcellular localization and association with stress granules is controlled by its Z-DNA binding domainsNikolaus Deigendesch, Friedrich Koch-Nolte, Stefan Rothenburg
Annual Review of Immunology|January 25, 2019
Purine Release, Metabolism, and Signaling in the Inflammatory ResponseJoel Linden, Friedrich Koch-Nolte, Gerhard Dahl
Frontiers in Cellular Neuroscience|November 7, 2014
Nanobodies as modulators of inflammation: potential applications for acute brain injuryBjörn Rissiek, Friedrich Koch-Nolte, Tim Magnus
Frontiers in Pharmacology|April 12, 2018
Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and ImmunityStephan Menzel, Nicole Schwarz, Friedrich Haag, et al.
Current Medicinal Chemistry|April 14, 2004
Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signalingMichel Seman, Sahil Adriouch, Friedrich Haag, et al.
Annals of the New York Academy of Sciences|March 23, 2004
T-cell survival regulator LKLF is not involved in inappropriate apoptosis of diabetes-prone BBDP rat T cellsPhilip Diessenbacher, Katrin Bartels, Friedrich Koch-Nolte, et al.
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Immunological Reviews|August 30, 2024
Nanobody-based heavy chain antibodies and chimeric antibodiesFriedrich Koch-Nolte
The FEBS Journal|June 19, 2013
Physiology of ADP-ribosylationFriedrich Koch-Nolte, Mathias Ziegler
Frontiers in Immunology|November 22, 2018
Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple MyelomaPeter Bannas, Friedrich Koch-Nolte
Frontiers in Immunology|December 8, 2017
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor TherapeuticsPeter Bannas, Julia Hambach, Friedrich Koch-Nolte
Nucleic Acids Research|September 23, 2006
ZBP1 subcellular localization and association with stress granules is controlled by its Z-DNA binding domainsNikolaus Deigendesch, Friedrich Koch-Nolte, Stefan Rothenburg
Annual Review of Immunology|January 25, 2019
Purine Release, Metabolism, and Signaling in the Inflammatory ResponseJoel Linden, Friedrich Koch-Nolte, Gerhard Dahl
Frontiers in Cellular Neuroscience|November 7, 2014
Nanobodies as modulators of inflammation: potential applications for acute brain injuryBjörn Rissiek, Friedrich Koch-Nolte, Tim Magnus
Frontiers in Pharmacology|April 12, 2018
Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and ImmunityStephan Menzel, Nicole Schwarz, Friedrich Haag, et al.
Current Medicinal Chemistry|April 14, 2004
Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signalingMichel Seman, Sahil Adriouch, Friedrich Haag, et al.
Annals of the New York Academy of Sciences|March 23, 2004
T-cell survival regulator LKLF is not involved in inappropriate apoptosis of diabetes-prone BBDP rat T cellsPhilip Diessenbacher, Katrin Bartels, Friedrich Koch-Nolte, et al.
Pageof 21